Kaplan-Meier estimates of the OS for different induction chemotherapy regimens. In MDS (A) and AML (B). Survival is expressed in months after induction. Each tick mark represents a censored patient. (A-B) No significant difference in survival among the induction regimens for patients with MDS or AML.